Agios Touts Encouraging Action From Sickle Cell Disease Study With Mitapivat

Agios Touts Encouraging Action From Sickle Cell Disease Study With Mitapivat

Submitted by admin on June 26, 2023 - 8:45pm
Source: 
Yahoo/Benzinga
News Tags: 
Agios Pharmaceuticals
clinical trials
sickle cell disase
mitapivat
Headline: 
Agios Touts Encouraging Action From Sickle Cell Disease Study With Mitapivat
snippet: 

Agios Pharmaceuticals Inc (NASDAQ: AGIO) announced that the Phase 2 portion of the global Phase 2/3 RISE UP study of mitapivat in sickle cell disease met its primary endpoint of hemoglobin response.

Do Not Allow Advertisers to Use My Personal information